Litcius/Paper detail

Enhertu (Fam-trastuzumab-deruxtecan-nxki) – Revolutionizing treatment paradigm for HER2-Low breast cancer

Tasmiyah Siddiqui, Payal Rani, Tayyaba Ashraf, Aayat Ellahi

2022Annals of Medicine and Surgery17 citationsDOIOpen Access PDF

Topics & Concepts

TrastuzumabMedicineBreast cancerOncologyInternal medicineGeneral surgeryCancerHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCancer Treatment and Pharmacology
Enhertu (Fam-trastuzumab-deruxtecan-nxki) – Revolutionizing treatment paradigm for HER2-Low breast cancer | Litcius